Back to BCAX

ACORN CAPITAL ADVISORS, LLC → BCAX

ACORN CAPITAL ADVISORS, LLC BCAX Position History

Bicara Therapeutics Inc. • Healthcare

Quarters held
4
Latest value
$12.4M
Q3 2026
Peak value
$19.1M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$10.8M
Q1 2026$12.8M
Q2 2026$19.1M
Q3 2026$12.4M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$12.4M668.4K——
Q2 2026$19.1M643.4K——
Q1 2026$12.8M643.4K——
Q4 2025$10.8M643.4K——

Other funds holding BCAX

Other ACORN CAPITAL ADVISORS, LLC positions

CGON

CG ONCOLOGY INC

$80.4M
CGON

CG ONCOLOGY INC

$80.2M
CGON

CG ONCOLOGY INC

$76.6M
URGN

UROGEN PHARMA LTD

$67M
URGN

UROGEN PHARMA LTD

$61.6M
CGON

CG ONCOLOGY INC

$47M
TRVI

TREVI THERAPEUTICS INC

$40M
CGC

CANDEL THERAPEUTICS INC

$36.5M